Curcuminoids from Curcuma longaL. reduced intestinal mucositis induced by 5-fluorouracil in mice: Bioadhesive, proliferative, anti-inflammatory and antioxidant effects

Toxicology Reports

Volumn 3, Issue , 2016, Pages 55-62

  dos Santos Filho, Edvande Xavier ^a   Ávila, Paulo Henrique Marcelino ^a   Bastos, Carla Caroline Cunha ^a   Batista, Aline Carvalho ^a   Naves, Letícia Nasser ^a   Marreto, Ricardo Neves ^a   Lima, Eliana Martins ^a   Mendonça, Elismauro Frascisco ^a   Valadares, Marize Campos ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

5 Fluorouracil; Curcuma longa L; Curcuminoids; Intestinal mucositis; Mucoadhesive formulation

Indexed keywords

CURCUMA LONGA EXTRACT; CURCUMINOID; FLUOROURACIL; KI 67 ANTIGEN; MALONALDEHYDE; MYELOPEROXIDASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BODY WEIGHT VARIATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY ASSESSMENT; DUODENUM DIVERTICULUM; HISTOLOGICAL SEVERITY SCORE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INCUBATION TEMPERATURE; INFLAMMATION; MALE; MORPHOMETRY; MUCOADHESION; MUCOSA INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; VOXEL BASED MORPHOMETRY;

EID: 85016945898     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2015.10.010     Document Type: Article

References (42)

1. Sonis, S.T., Elting, L.S., Keefe, D., Peterson, D.E., Schubert, M., Hauer-Jensen, M., Bekele, B.N., Raber-Durlacher, J., Donnelly, J.P., Rubenstein, E.B., Mucositis Study Section of the Multinational Association for Supportive Care in Cancer, International Society for Oral Oncology, Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 (2004), 1995–2025, 10.1002/cncr.20162.
2. Sonis, S.T., Regimen-related gastrointestinal toxicities in cancer patients. Curr. Opin. Support Palliat Care 4 (2010), 26–30, 10.1097/SPC.0b013e328335fb76.
3. Van Vliet, M.J., Harmsen, H.J., de Bont, E.S., Tissing, W.J., The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog., 6, 2010, e1000879, 10.1371/journal.ppat.1000879.
4. Villa, A., Sonis, S.T., Mucositis: pathobiology and management. Curr. Opin. Oncol. 27 (2015), 159–164, 10.1097/CCO.0000000000000180.
5. Benz, C., Degregorio, M., Saks, S., Sambol, N., Holleran, W., Ignoffo, R., Lewis, B., Cadman, E., Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response. Cancer Res. 45 (1985), 3354–3358.
6. Van Sebille, Y.Z., Stansborough, R., Wardill, H.R., Bateman, E., Gibson, R.J., Keefe, D.M., Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics. Curr. Oncol. Rep., 17, 2015, 10.1007/s11912-015-0474-9.
7. Posner, M.R., Haddad, R.I., Novel agents for the treatment of mucositis. J. Support Oncol. 5 (2007), 33–39.
8. Rubenstein, E.B., Peterson, D.E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., Elting, L.S., Fox, P.C., Cooksley, C., Sonis, S.T., Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology,clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100 (2004), 2026–2046, 10.1002/cncr.20163.
9. Keefe, D.M., Sonis, S.T., Bowen, J.M., Emerging drugs for chemotherapy-induced mucositis. Expert Opin. Emerg. Drugs 13 (2008), 511–522, 10.1517/14728214.13.3.511.
10. Reinke, D., Kritas, S., Polychronopoulos, P., Skaltsounis, A.L., Aligiannis, N., Tran, C.D., Herbal substance, acteoside, alleviates intestinal mucositis in mice. Gastroenterol Res. Pract., 2015, 2015, 10.1155/2015/327872.
11. Wright, T.H., Yazbeck, R., Lymn, K.A., Whitford, E.J., Cheah, K.Y., Butler, R.N., Feinle-Bisset, C., Pilichiewicz, A.N., Mashtoub, S., Howarth, G.S., The herbal extract, iberogast, improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis. Cancer Biol. Ther. 8 (2009), 923–929, 10.4161/cbt.8.10.8146.
12. Liu, Z., Xi, J., Schröder, S., Wang, W., Xie, T., Wang, Z., Bao, S., Chimonanthus nitens var. salicifolius aqueous extract protects against 5-fluorouracil induced gastrointestinal mucositis in a mouse model. Evid. Based Compl. Alt. Med., 2013, 2013, 10.1155/2013/789263.
13. Ávila, P.H.M., Ávila, R.I., Filho, E.X.S., Bastos, C.C.C., Batista, A.C., Mendonça, E.F., Serpa, R.C., Marreto, R.N., Cruz, A.F., Lima, E.M., Valadares, M.C., Mucoadhesive formulation of Bidens pilosa L. (Asteraceae) reduces intestinal injury from 5-fluorouracil-induced mucositis in mice. Toxicol. Rep. 2 (2015), 563–573, 10.1016/j.toxrep.2015.03.003.
14. Loo, W.T., Jin, L.J., Chow, L.W., Cheung, M.N., Wang, M., Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients. Expert Opin. Investig. Drugs 19:Suppl. 1 (2010), 91–100, 10.1517/13543781003727057.
15. Gupta, S.C., Sung, B., Kim, J.H., Prasad, S., Li, S., Aggarwal, B.B., Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol. Nutr. Food Res. 57 (2013), 1510–1528, 10.1002/mnfr.201100741.
16. Naksuriya, O., Okonogi, S., Schiffelers, R.M., Hennink, W.E., Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterial 35 (2014), 3365–3383, 10.1016/j.biomaterials.2013.12.090.
17. Li, S.Y., Yuan, W., Deng, G.R., Wang, P., Yang, P., Aggarwal, B.B., Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm. Crops. 2 (2011), 28–54.
18. Varum, F.J., McConnell, E.L., Sousa, J.J., Veiga, F., Basit, A.W., Mucoadhesion and the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier. Syst. 25 (2008), 207–258, 10.1615/CritRevTherDrugCarrierSyst.v25. i3.10.
19. Hubrecht, R., Kirkwood, J., The UFAW Handbook on the Care and Management of Laboratory and Other Research Animals. 8th ed., 2010, Wiley-Blackwell, United Kingdom.
20. Bradley, P.P., Christensen, R.D., Rothstein, G., Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60 (1982), 618–622.
21. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95 (1979), 351–358.
22. Lima-Júnior, R.C., Figueiredo, A.A., Freitas, H.C., Melo, M.L., Wong, D.V., Leite, C.A., Medeiros, R.P., Marques-Neto, R.D., Vale, M.L., Brito, G.A., Oriá R.B., Souza, M.H., Cunha, F.Q., Ribeiro, R.A., Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation. Cancer. Chemother. Pharmacol. 4 (2012), 931–942, 10.1007/s00280-011-1780-z.
23. Okur, H., Küçükaydin, M., Köse, K., Kontaş O., Doğam, P., Kazez, A., Hypoxia-induced necrotizing enterocolitis in the immature rat: the role of lipid peroxidation and management by vitamin E. J. Pediatr. Surg. 10 (1995), 1416–1419.
24. Sá O.M.S., Lopes, N.N.F., Alves, M.T.S., Lalla, R.V., Oliva, M.L.V., Caran, E.M.M., Glycine supplementation reduces the severity of chemotherapy-induced oral mucositis in hamsters. Nat. Sci. 5 (2013), 972–978, 10.4236/ns.2013.59118.
25. McGuire, D.B., Fulton, J.S., Park, J., Brown, C.G., Correa, M.E.P., Eilers, J., Elad, S., Gibson, F., Oberle-Edwards, L.K., Bowen, J., Lalla, R.V., Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support. Care Cancer 21 (2013), 3165–3177, 10.1007/s00520-013-1942-0.
26. Nicolatou-Galitis, O., Sarri, T., Bowen, J., Di Palma, M., Kouloulias, V.E., Niscola, P., Riesenbeck, D., Stokman, M., Tissing, W., Yeoh, E., Elad, S., Lalla, R.V., Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support. Care Cancer 21 (2013), 3179–3189, 10.1007/s00520-013-1847-y.
27. Saunders, D.P., Epstein, J.B., Elad, S., Allemano, J., Bossi, P., van de Wetering, M.D., Rao, N.G., Potting, C., Cheng, K.K., Freidank, A., Brennan, M.T., Bowen, J., Dennis, K., Lalla, R.V., Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support. Care Cancer 21 (2013), 3191–3207, 10.1007/s00520-013-1871-y.
28. Oton-Leite, A.F., Silva, G.B., Morais, M.O., Silva, T.A., Leles, C.R., Valadares, M.C., Pinezi, J.C., Batista, A.C., Mendonça, E.F., Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients. Lasers Surg. Med. 47 (2015), 296–305, 10.1002/lsm.22349.
29. Cool, J.C., Dyer, J.L., Xian, C.J., Butler, R.N., Geier, M.S., Howarth, G.S., Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats. Growth Horm. IGF Res. 15 (2005), 72–82, 10.1016/j.ghir.2004.12.002.
30. Son, T.G., Gong, E.J., Bae, M.J., Kim, S.D., Heo, K., Moon, C., Yang, K., Kim, J.S., Protective effect of genistein on radiation-induced intestinal injury in tumor bearing mice. BMC Complement Altern. Med., 13, 2013, 10.1186/1472-6882-13-103.
31. Stein, A., Voigt, W., Jordan, K., Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther. Adv. Med. Oncol. 2 (2010), 51–63, 10.1007/s00520-013-1871-y.
32. Ferreira, T.M., Leonel, A.J., Melo, M.A., Santos, R.R., Cara, D.C., Cardoso, V.N., Correia, M.I., Alvarez-Leite, J.I., Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids 47 (2012), 669–678, 10.1007/s11745-012-3680-3.
33. Pritchard, D.M., Potten, C.S., Hickman, J.A., The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res. 58 (1998), 5453–5465.
34. Al-Refai, A.S., Immunohistochemical study of the effect of chamomile extract on 5-fluorouracil induced intestinal mucositis in Albino rats. J. Clin. Cell Immunol., 5, 2014, 10.4172/2155-9899.1000232.
35. Marques, L.H.S., Silva, C.M.G., Lameiro, T.M.M., Almeida, M.G., Cunha, F.L., Pereira, J.A., Martinez, C.A.R., Evaluation of lipid peroxidation levels on mucosa colonic cells after application of hydrogen peroxide in enemas. Experimental study in rats. Rev. Bras. Colo-Proctol. 30 (2010), 272–280.
36. Cunha, F.L., Silva, C.M.G., Almeida, M.G., Lameiro, T.M.M., Marques, L.H.S., Margarido, N.F., Martinez, C.A., Reduction in oxidative stress levels in the colonic mucosa without fecal stream after the application of enemas containing aqueous Ilex paraguariensis extract. Acta Cir. Bras. 26 (2011), 289–296.
37. Grabovac, V., Guggi, D., Bernkop-Schnürch, A.A., Comparison of the mucoadhesive properties of various polymers. Adv. Drug Deliv. Rev. 57 (2005), 1713–1723, 10.1016/j.addr.2005.07.006.
38. Chinna Reddy, P., Chaitanya, K.S., Madhusudan Rao, Y., A Review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. Daru 19 (2011), 385–403.
39. Chen, M.J., Cheng, Y.M., Lai, P.H., Wu, J.F., Hsu, Y.C., In vitro biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemoprevention. Int. J. Colorectal Dis. 27 (2012), 869–878, 10.1007/s00384-011-1393-3.
40. Prasad, S., Tyagi, A.K., Aggarwal, B.B., Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res. Treat. 46 (2014), 2–18, 10.4143/crt.2014.46.1.2.
41. Yang, K.Y., Lin, L.C., Tseng, T.Y., Wang, S.C., Tsai, T.H., Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 853 (2007), 183–189, 10.1016/j.jchromb.2007.03.010.
42. Henrotin, Y., Priem, F., Mobasheri, A., Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis curcumin for osteoarthritis management. Springerplus, 2, 2013, 10.1186/2193-1801-2-56.